Old Web
English
Sign In
Acemap
>
Paper
>
Real-World Clinical Outcomes of Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
Real-World Clinical Outcomes of Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
2020
Yoshifumi Kadono
Shohei Kawaguchi
Takahiro Nohara
Kazuyoshi Shigehara
Kouji Izumi
Taiki Kamijima
Chikashi Seto
Akinobu Takano
Satoshi Yotsuyanagi
Ryunosuke Nakagawa
Tohru Miyagi
Shuhei Aoyama
Hideki Asahi
Rie Fukuda
Atsushi Mizokami
Keywords:
Oncology
Internal medicine
Medicine
Second-line therapy
Pembrolizumab
urothelial carcinoma
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]